The impact of different GFR estimating equations on the prevalence of CKD and risk groups in a Southeast Asian cohort using the new KDIGO guidelines
Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) group recommended that patients with CKD should be assigned to stages and composite relative risk groups according to GFR (G) and proteinuria (A) criteria. Asians have among the highest rates of ESRD in the world, but establishing the p...
Saved in:
Published in | BMC nephrology Vol. 13; no. 1; p. 1 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
06.01.2012
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) group recommended that patients with CKD should be assigned to stages and composite relative risk groups according to GFR (G) and proteinuria (A) criteria. Asians have among the highest rates of ESRD in the world, but establishing the prevalence and prognosis CKD is a problem for Asian populations since there is no consensus on the best GFR estimating (eGFR) equation. We studied the effects of the choice of new Asian and Caucasian eGFR equations on CKD prevalence, stage distribution, and risk categorization using the new KDIGO classification.
The prevalence of CKD and composite relative risk groups defined by eGFR from with Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI); standard (S) or Chinese(C) MDRD; Japanese CKD-EPI (J-EPI), Thai GFR (T-GFR) equations were compared in a Thai cohort (n = 5526)
There was a 7 fold difference in CKD3-5 prevalence between J-EPI and the other Asian eGFR formulae. CKD3-5 prevalence with S-MDRD and CKD-EPI were 2 - 3 folds higher than T-GFR or C-MDRD. The concordance with CKD-EPI to diagnose CKD3-5 was over 90% for T-GFR or C-MDRD, but they only assigned the same CKD stage in 50% of the time. The choice of equation also caused large variations in each composite risk groups especially those with mildly increased risks. Different equations can lead to a reversal of male: female ratios. The variability of different equations is most apparent in older subjects. Stage G3aA1 increased with age and accounted for a large proportion of the differences in CKD3-5 between CKD-EPI, S-MDRD and C-MDRD.
CKD prevalence, sex ratios, and KDIGO composite risk groupings varied widely depending on the equation used. More studies are needed to define the best equation for Asian populations. |
---|---|
AbstractList | Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) group recommended that patients with CKD should be assigned to stages and composite relative risk groups according to GFR (G) and proteinuria (A) criteria. Asians have among the highest rates of ESRD in the world, but establishing the prevalence and prognosis CKD is a problem for Asian populations since there is no consensus on the best GFR estimating (eGFR) equation. We studied the effects of the choice of new Asian and Caucasian eGFR equations on CKD prevalence, stage distribution, and risk categorization using the new KDIGO classification. The prevalence of CKD and composite relative risk groups defined by eGFR from with Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI); standard (S) or Chinese(C) MDRD; Japanese CKD-EPI (J-EPI), Thai GFR (T-GFR) equations were compared in a Thai cohort (n = 5526) There was a 7 fold difference in CKD.sub.3-5 prevalence between J-EPI and the other Asian eGFR formulae. CKD.sub.3-5 prevalence with S-MDRD and CKD-EPI were 2 - 3 folds higher than T-GFR or C-MDRD. The concordance with CKD-EPI to diagnose CKD.sub.3-5 was over 90% for T-GFR or C-MDRD, but they only assigned the same CKD stage in 50% of the time. The choice of equation also caused large variations in each composite risk groups especially those with mildly increased risks. Different equations can lead to a reversal of male: female ratios. The variability of different equations is most apparent in older subjects. Stage G3aA1 increased with age and accounted for a large proportion of the differences in CKD.sub.3-5 between CKD-EPI, S-MDRD and C-MDRD. CKD prevalence, sex ratios, and KDIGO composite risk groupings varied widely depending on the equation used. More studies are needed to define the best equation for Asian populations. BACKGROUND: Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) group recommended that patients with CKD should be assigned to stages and composite relative risk groups according to GFR (G) and proteinuria (A) criteria. Asians have among the highest rates of ESRD in the world, but establishing the prevalence and prognosis CKD is a problem for Asian populations since there is no consensus on the best GFR estimating (eGFR) equation. We studied the effects of the choice of new Asian and Caucasian eGFR equations on CKD prevalence, stage distribution, and risk categorization using the new KDIGO classification. METHODS: The prevalence of CKD and composite relative risk groups defined by eGFR from with Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI); standard (S) or Chinese(C) MDRD; Japanese CKD-EPI (J-EPI), Thai GFR (T-GFR) equations were compared in a Thai cohort (n = 5526) RESULTS: There was a 7 fold difference in CKD3-5 prevalence between J-EPI and the other Asian eGFR formulae. CKD3-5 prevalence with S-MDRD and CKD-EPI were 2 - 3 folds higher than T-GFR or C-MDRD. The concordance with CKD-EPI to diagnose CKD3-5 was over 90% for T-GFR or C-MDRD, but they only assigned the same CKD stage in 50% of the time. The choice of equation also caused large variations in each composite risk groups especially those with mildly increased risks. Different equations can lead to a reversal of male: female ratios. The variability of different equations is most apparent in older subjects. Stage G3aA1 increased with age and accounted for a large proportion of the differences in CKD3-5 between CKD-EPI, S-MDRD and C-MDRD. CONCLUSIONS: CKD prevalence, sex ratios, and KDIGO composite risk groupings varied widely depending on the equation used. More studies are needed to define the best equation for Asian populations. Abstract Background Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) group recommended that patients with CKD should be assigned to stages and composite relative risk groups according to GFR (G) and proteinuria (A) criteria. Asians have among the highest rates of ESRD in the world, but establishing the prevalence and prognosis CKD is a problem for Asian populations since there is no consensus on the best GFR estimating (eGFR) equation. We studied the effects of the choice of new Asian and Caucasian eGFR equations on CKD prevalence, stage distribution, and risk categorization using the new KDIGO classification. Methods The prevalence of CKD and composite relative risk groups defined by eGFR from with Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI); standard (S) or Chinese(C) MDRD; Japanese CKD-EPI (J-EPI), Thai GFR (T-GFR) equations were compared in a Thai cohort (n = 5526) Results There was a 7 fold difference in CKD3-5 prevalence between J-EPI and the other Asian eGFR formulae. CKD3-5 prevalence with S-MDRD and CKD-EPI were 2 - 3 folds higher than T-GFR or C-MDRD. The concordance with CKD-EPI to diagnose CKD3-5 was over 90% for T-GFR or C-MDRD, but they only assigned the same CKD stage in 50% of the time. The choice of equation also caused large variations in each composite risk groups especially those with mildly increased risks. Different equations can lead to a reversal of male: female ratios. The variability of different equations is most apparent in older subjects. Stage G3aA1 increased with age and accounted for a large proportion of the differences in CKD3-5 between CKD-EPI, S-MDRD and C-MDRD. Conclusions CKD prevalence, sex ratios, and KDIGO composite risk groupings varied widely depending on the equation used. More studies are needed to define the best equation for Asian populations. BACKGROUNDRecently, the Kidney Disease: Improving Global Outcomes (KDIGO) group recommended that patients with CKD should be assigned to stages and composite relative risk groups according to GFR (G) and proteinuria (A) criteria. Asians have among the highest rates of ESRD in the world, but establishing the prevalence and prognosis CKD is a problem for Asian populations since there is no consensus on the best GFR estimating (eGFR) equation. We studied the effects of the choice of new Asian and Caucasian eGFR equations on CKD prevalence, stage distribution, and risk categorization using the new KDIGO classification. METHODSThe prevalence of CKD and composite relative risk groups defined by eGFR from with Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI); standard (S) or Chinese(C) MDRD; Japanese CKD-EPI (J-EPI), Thai GFR (T-GFR) equations were compared in a Thai cohort (n = 5526) RESULTSThere was a 7 fold difference in CKD3-5 prevalence between J-EPI and the other Asian eGFR formulae. CKD3-5 prevalence with S-MDRD and CKD-EPI were 2 - 3 folds higher than T-GFR or C-MDRD. The concordance with CKD-EPI to diagnose CKD3-5 was over 90% for T-GFR or C-MDRD, but they only assigned the same CKD stage in 50% of the time. The choice of equation also caused large variations in each composite risk groups especially those with mildly increased risks. Different equations can lead to a reversal of male: female ratios. The variability of different equations is most apparent in older subjects. Stage G3aA1 increased with age and accounted for a large proportion of the differences in CKD3-5 between CKD-EPI, S-MDRD and C-MDRD. CONCLUSIONSCKD prevalence, sex ratios, and KDIGO composite risk groupings varied widely depending on the equation used. More studies are needed to define the best equation for Asian populations. Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) group recommended that patients with CKD should be assigned to stages and composite relative risk groups according to GFR (G) and proteinuria (A) criteria. Asians have among the highest rates of ESRD in the world, but establishing the prevalence and prognosis CKD is a problem for Asian populations since there is no consensus on the best GFR estimating (eGFR) equation. We studied the effects of the choice of new Asian and Caucasian eGFR equations on CKD prevalence, stage distribution, and risk categorization using the new KDIGO classification. The prevalence of CKD and composite relative risk groups defined by eGFR from with Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI); standard (S) or Chinese(C) MDRD; Japanese CKD-EPI (J-EPI), Thai GFR (T-GFR) equations were compared in a Thai cohort (n = 5526) There was a 7 fold difference in CKD3-5 prevalence between J-EPI and the other Asian eGFR formulae. CKD3-5 prevalence with S-MDRD and CKD-EPI were 2 - 3 folds higher than T-GFR or C-MDRD. The concordance with CKD-EPI to diagnose CKD3-5 was over 90% for T-GFR or C-MDRD, but they only assigned the same CKD stage in 50% of the time. The choice of equation also caused large variations in each composite risk groups especially those with mildly increased risks. Different equations can lead to a reversal of male: female ratios. The variability of different equations is most apparent in older subjects. Stage G3aA1 increased with age and accounted for a large proportion of the differences in CKD3-5 between CKD-EPI, S-MDRD and C-MDRD. CKD prevalence, sex ratios, and KDIGO composite risk groupings varied widely depending on the equation used. More studies are needed to define the best equation for Asian populations. BackgroundRecently, the Kidney Disease: Improving Global Outcomes (KDIGO) group recommended that patients with CKD should be assigned to stages and composite relative risk groups according to GFR (G) and proteinuria (A) criteria. Asians have among the highest rates of ESRD in the world, but establishing the prevalence and prognosis CKD is a problem for Asian populations since there is no consensus on the best GFR estimating (eGFR) equation. We studied the effects of the choice of new Asian and Caucasian eGFR equations on CKD prevalence, stage distribution, and risk categorization using the new KDIGO classification.MethodsThe prevalence of CKD and composite relative risk groups defined by eGFR from with Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI); standard (S) or Chinese(C) MDRD; Japanese CKD-EPI (J-EPI), Thai GFR (T-GFR) equations were compared in a Thai cohort (n = 5526)ResultsThere was a 7 fold difference in CKD.sub.3-5 prevalence between J-EPI and the other Asian eGFR formulae. CKD.sub.3-5 prevalence with S-MDRD and CKD-EPI were 2 - 3 folds higher than T-GFR or C-MDRD. The concordance with CKD-EPI to diagnose CKD.sub.3-5 was over 90% for T-GFR or C-MDRD, but they only assigned the same CKD stage in 50% of the time. The choice of equation also caused large variations in each composite risk groups especially those with mildly increased risks. Different equations can lead to a reversal of male: female ratios. The variability of different equations is most apparent in older subjects. Stage G3aA1 increased with age and accounted for a large proportion of the differences in CKD.sub.3-5 between CKD-EPI, S-MDRD and C-MDRD.ConclusionsCKD prevalence, sex ratios, and KDIGO composite risk groupings varied widely depending on the equation used. More studies are needed to define the best equation for Asian populations. |
ArticleNumber | 1 |
Audience | Academic |
Author | Kitiyakara, Chagriya Vanavanan, Somlak Hengprasith, Bunlue Sritara, Piyamitr Yamwong, Sukit Vathesatogkit, Prin Chittamma, Anchalee Cheepudomwit, Sayan |
AuthorAffiliation | 1 Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok10110, Thailand 3 Medical and Health Office, Electricity Generating Authority of Thailand, Bangkruay, Nonthaburi 11130, Thailand 2 Division of Clinical Chemistry, Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10110, Thailand |
AuthorAffiliation_xml | – name: 3 Medical and Health Office, Electricity Generating Authority of Thailand, Bangkruay, Nonthaburi 11130, Thailand – name: 2 Division of Clinical Chemistry, Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10110, Thailand – name: 1 Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok10110, Thailand |
Author_xml | – sequence: 1 givenname: Chagriya surname: Kitiyakara fullname: Kitiyakara, Chagriya email: kitiyakc@yahoo.com organization: Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok10110, Thailand. kitiyakc@yahoo.com – sequence: 2 givenname: Sukit surname: Yamwong fullname: Yamwong, Sukit – sequence: 3 givenname: Prin surname: Vathesatogkit fullname: Vathesatogkit, Prin – sequence: 4 givenname: Anchalee surname: Chittamma fullname: Chittamma, Anchalee – sequence: 5 givenname: Sayan surname: Cheepudomwit fullname: Cheepudomwit, Sayan – sequence: 6 givenname: Somlak surname: Vanavanan fullname: Vanavanan, Somlak – sequence: 7 givenname: Bunlue surname: Hengprasith fullname: Hengprasith, Bunlue – sequence: 8 givenname: Piyamitr surname: Sritara fullname: Sritara, Piyamitr |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22226403$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kktv1DAQxyNURB9w5YgseuCU4kcSxxek1ZYuq1aqBOVsOfYk65K1t3ZSxPfgA-OwZdWFYh88Gv_nZ8_jODtw3kGWvSb4jJC6ek8KTnLKKpETlpNn2dHOcfDIPsyOY7zFmPC6wC-yQ5pWVWB2lP28WQGy643SA_ItMrZtIYAb0OLiM4I42LUarOsQ3I3J8C4i79CQYjYB7lUPTsMUN788R8oZFGz8hrrgx01E1iGFvvgxqVUc0Cxa5ZD2Kx8GNMYJOnEcfEeX58vFNepGa6C3DuLL7Hmr-givHs6T7OvFx5v5p_zqerGcz67ypsJ8yBuuaqC1AAIM06ZQBoQoSo1Zieta04IqLExtWFNyYlpVQcsq4LTVohC8IuwkW265xqtbuQkp2fBDemXlb4cPnVRhsLoHqQrGq6KsVFmbAhMjWs7auhFGUCq0Yon1YcvajM0ajE41DKrfg-7fOLuSnb-XjPKiYBNgtgU01v8HsH-j_VpOHZZThyVhckro3cMngr8bU_vk2kYNfa8c-DFKQXGagIrjpHz7l_LWj8Glak8izEvCJ9zpVtSlTkvrWp8e1hNSzigXgou6rJLq7AlV2gbWVqdxbW3yPxWgg48xQLtLkmA5TfW_ab15XNud_M8Ys195evOB |
CitedBy_id | crossref_primary_10_1016_j_kisu_2017_07_005 crossref_primary_10_1038_s41598_021_00694_9 crossref_primary_10_1016_j_cca_2013_02_025 crossref_primary_10_1038_s41598_017_02355_2 crossref_primary_10_1038_ki_2015_212 crossref_primary_10_1136_bmjspcare_2021_003182 crossref_primary_10_1007_s40620_023_01749_y crossref_primary_10_1007_s40200_018_0338_6 crossref_primary_10_1053_j_ajkd_2013_12_006 crossref_primary_10_1136_bmjopen_2018_024739 crossref_primary_10_1016_j_jdiacomp_2016_06_001 crossref_primary_10_1016_S0140_6736_13_60687_X crossref_primary_10_1371_journal_pone_0300428 crossref_primary_10_1016_j_amjms_2016_04_017 crossref_primary_10_25259_SAJHS_2_2024 crossref_primary_10_1186_s13104_019_4692_3 crossref_primary_10_2147_IJN_S347164 crossref_primary_10_1186_s40697_015_0076_3 |
Cites_doi | 10.7326/0003-4819-150-9-200905050-00006 10.1016/S0140-6736(10)60674-5 10.1152/jappl.2000.89.1.81 10.5414/CNP72337 10.1053/j.ajkd.2008.12.034 10.1093/ije/dyg105 10.1038/ki.2010.462 10.1681/ASN.2006040368 10.7326/0003-4819-145-4-200608150-00004 10.1038/ki.1985.3 10.1053/j.ajkd.2007.10.047 10.1373/clinchem.2005.0525144 10.1053/j.ajkd.2010.02.337 10.1007/s00421-006-0375-6 10.1038/sj.ki.5002701 10.2337/dc05-2141 10.1373/clinchem.2006.077180 10.1053/j.ajkd.2009.02.011 10.1159/000151244 10.1016/S0272-6386(12)81022-5 10.7326/0003-4819-130-6-199903160-00002 10.1053/j.ajkd.2010.02.344 10.2215/CJN.03720708 10.5414/CNP74358 10.1093/ndt/gfp669 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2012 BioMed Central Ltd. 2012 Kitiyakara et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Copyright ©2012 Kitiyakara et al; licensee BioMed Central Ltd. 2012 Kitiyakara et al; licensee BioMed Central Ltd. |
Copyright_xml | – notice: COPYRIGHT 2012 BioMed Central Ltd. – notice: 2012 Kitiyakara et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. – notice: Copyright ©2012 Kitiyakara et al; licensee BioMed Central Ltd. 2012 Kitiyakara et al; licensee BioMed Central Ltd. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7QP 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/1471-2369-13-1 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals (DOAJ) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Statistics |
EISSN | 1471-2369 |
EndPage | 1 |
ExternalDocumentID | oai_doaj_org_article_a4376456a58d401d9f73f8b9d9229ca3 oai_biomedcentral_com_1471_2369_13_1 2579709471 A279979856 10_1186_1471_2369_13_1 22226403 |
Genre | Research Support, Non-U.S. Gov't Journal Article Comparative Study |
GeographicLocations | Asia, Southeastern |
GeographicLocations_xml | – name: Asia, Southeastern |
GroupedDBID | --- -A0 0R~ 23N 2VQ 2WC 3V. 4.4 53G 5GY 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AAWTL ABUWG ACGFO ACGFS ACIHN ACPRK ACRMQ ADBBV ADINQ ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHSBF AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C24 C6C CCPQU CGR CS3 CUY CVF DIK DU5 E3Z EBD EBLON EBS ECM EIF EJD EMB EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR IPNFZ ITC KQ8 M1P M48 M~E NPM O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC PSQYO RBZ RIG RNS ROL RPM RSV SMD SOJ SV3 TR2 UKHRP W2D WOQ WOW XSB AAYXX CITATION ABVAZ AFGXO AFNRJ 7QP 7XB 8FK AZQEC DWQXO K9. PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-b607t-b7a8e289e1e302b4ade9945c035088c242a09d8d3b571dfa6ef36e72fc9497613 |
IEDL.DBID | RBZ |
ISSN | 1471-2369 |
IngestDate | Sun Sep 29 07:11:17 EDT 2024 Tue Sep 17 20:37:36 EDT 2024 Wed May 22 07:16:04 EDT 2024 Fri Aug 16 01:45:06 EDT 2024 Thu Oct 10 19:46:08 EDT 2024 Thu Feb 22 23:42:18 EST 2024 Wed Jan 10 04:24:32 EST 2024 Thu Sep 12 17:48:34 EDT 2024 Sat Sep 28 07:59:30 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b607t-b7a8e289e1e302b4ade9945c035088c242a09d8d3b571dfa6ef36e72fc9497613 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://dx.doi.org/10.1186/1471-2369-13-1 |
PMID | 22226403 |
PQID | 920075171 |
PQPubID | 44769 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_a4376456a58d401d9f73f8b9d9229ca3 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3274433 biomedcentral_primary_oai_biomedcentral_com_1471_2369_13_1 proquest_miscellaneous_920784670 proquest_journals_920075171 gale_infotracmisc_A279979856 gale_infotracacademiconefile_A279979856 crossref_primary_10_1186_1471_2369_13_1 pubmed_primary_22226403 |
PublicationCentury | 2000 |
PublicationDate | 2012-01-06 |
PublicationDateYYYYMMDD | 2012-01-06 |
PublicationDate_xml | – month: 01 year: 2012 text: 2012-01-06 day: 06 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC nephrology |
PublicationTitleAlternate | BMC Nephrol |
PublicationYear | 2012 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | 10904038 - J Appl Physiol (1985). 2000 Jul;89(1):81-8 20416999 - Am J Kidney Dis. 2010 Jul;56(1):32-8 21289598 - Kidney Int. 2011 Jun;79(12):1331-40 19101400 - Am J Kidney Dis. 2009 Jan;53(1):166-74 3920429 - Kidney Int. 1985 Jan;27(1):9-16 21307840 - Kidney Int. 2011 Jun;79(12):1341-52 17332152 - Clin Chem. 2007 Apr;53(4):766-72 19005012 - Clin J Am Soc Nephrol. 2009 Jan;4(1):77-85 21289597 - Kidney Int. 2011 Jul;80(1):93-104 16908915 - Ann Intern Med. 2006 Aug 15;145(4):247-54 18431892 - J Med Assoc Thai. 2007 Oct;90 Suppl 1:98-108 20979944 - Clin Nephrol. 2010 Nov;74(5):358-63 12777437 - Int J Epidemiol. 2003 Jun;32(3):461-8 20483451 - Lancet. 2010 Jun 12;375(9731):2073-81 16988059 - J Am Soc Nephrol. 2006 Oct;17(10):2937-44 10075613 - Ann Intern Med. 1999 Mar 16;130(6):461-70 18689986 - Nephron Clin Pract. 2008;110(1):c39-46; discussion c47 19463761 - Am J Kidney Dis. 2009 Jun;53(6):932-5 19414839 - Ann Intern Med. 2009 May 5;150(9):604-12 19863875 - Clin Nephrol. 2009 Nov;72(5):337-43 11904577 - Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266 20338463 - Am J Kidney Dis. 2010 Apr;55(4):622-7 21107446 - Kidney Int. 2011 Mar;79(5):555-62 21150873 - Kidney Int. 2011 Jul;80(1):17-28 17186296 - Eur J Appl Physiol. 2007 Mar;99(5):475-83 21357214 - Nephrol Dial Transplant. 2011 Sep;26(9):2780-5 20037182 - Nephrol Dial Transplant. 2010 May;25(5):1567-75 19339088 - Am J Kidney Dis. 2009 Jun;53(6):982-92 16332993 - Clin Chem. 2006 Jan;52(1):5-18 16873795 - Diabetes Care. 2006 Aug;29(8):1872-7 18059458 - Kidney Int. 2008 Feb;73(4):473-9 2205098 - Am J Kidney Dis. 1990 Sep;16(3):224-35 AS Levey (256_CR8) 1999; 130 YC Ma (256_CR9) 2006; 17 GL Myers (256_CR19) 2006; 52 LA Stevens (256_CR23) 2011; 79 RJ Glassock (256_CR7) 2008; 110 S Matsuo (256_CR10) 2009; 53 P Hutayanon (256_CR18) 2007; 90 MP Hossain (256_CR6) 2009; 53 AD Rule (256_CR25) 2009; 53 K Praditpornsilpa (256_CR14) 2011 P Sritara (256_CR15) 2003; 32 RT Gansevoort (256_CR4) 2011 D Giavarina (256_CR22) 2010; 74 K Sanada (256_CR26) 2007; 99 W Aekplakorn (256_CR16) 2006; 29 RD Perrone (256_CR31) 1990; 16 AS Levey (256_CR17) 2006; 145 BC Astor (256_CR3) 2011 A Ingsathit (256_CR20) 2010; 25 AS Levey (256_CR1) 2010 WM Michels (256_CR29) 2009; 72 AS Levey (256_CR12) 2009; 150 B Odlind (256_CR30) 1985; 27 AS Levey (256_CR11) 2010; 55 M Horio (256_CR13) 2010; 56 M van der Velde (256_CR24) 2011 AS Levey (256_CR21) 2007; 53 K Matsushita (256_CR5) 2010; 375 R Agarwal (256_CR28) 2009; 4 I Janssen (256_CR27) 2000; 89 256_CR2 V Perkovic (256_CR32) 2008; 73 |
References_xml | – volume: 150 start-page: 604 issue: 9 year: 2009 ident: 256_CR12 publication-title: Ann Intern Med doi: 10.7326/0003-4819-150-9-200905050-00006 contributor: fullname: AS Levey – volume: 375 start-page: 2073 issue: 9731 year: 2010 ident: 256_CR5 publication-title: Lancet doi: 10.1016/S0140-6736(10)60674-5 contributor: fullname: K Matsushita – volume-title: Kidney Int year: 2010 ident: 256_CR1 contributor: fullname: AS Levey – volume: 89 start-page: 81 issue: 1 year: 2000 ident: 256_CR27 publication-title: J Appl Physiol doi: 10.1152/jappl.2000.89.1.81 contributor: fullname: I Janssen – volume: 72 start-page: 337 issue: 5 year: 2009 ident: 256_CR29 publication-title: Clin Nephrol doi: 10.5414/CNP72337 contributor: fullname: WM Michels – volume: 53 start-page: 982 issue: 6 year: 2009 ident: 256_CR10 publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2008.12.034 contributor: fullname: S Matsuo – volume-title: Kidney Int year: 2011 ident: 256_CR4 contributor: fullname: RT Gansevoort – volume: 32 start-page: 461 issue: 3 year: 2003 ident: 256_CR15 publication-title: Int J Epidemiol doi: 10.1093/ije/dyg105 contributor: fullname: P Sritara – volume: 90 start-page: 98 issue: Suppl 1 year: 2007 ident: 256_CR18 publication-title: J Med Assoc Thai contributor: fullname: P Hutayanon – volume: 79 start-page: 555 issue: 5 year: 2011 ident: 256_CR23 publication-title: Kidney Int doi: 10.1038/ki.2010.462 contributor: fullname: LA Stevens – volume: 17 start-page: 2937 issue: 10 year: 2006 ident: 256_CR9 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2006040368 contributor: fullname: YC Ma – volume: 145 start-page: 247 issue: 4 year: 2006 ident: 256_CR17 publication-title: Ann Intern Med doi: 10.7326/0003-4819-145-4-200608150-00004 contributor: fullname: AS Levey – ident: 256_CR2 – volume: 27 start-page: 9 issue: 1 year: 1985 ident: 256_CR30 publication-title: Kidney Int doi: 10.1038/ki.1985.3 contributor: fullname: B Odlind – volume: 53 start-page: 166 issue: 1 year: 2009 ident: 256_CR6 publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2007.10.047 contributor: fullname: MP Hossain – volume: 52 start-page: 5 issue: 1 year: 2006 ident: 256_CR19 publication-title: Clin Chem doi: 10.1373/clinchem.2005.0525144 contributor: fullname: GL Myers – volume: 55 start-page: 622 issue: 4 year: 2010 ident: 256_CR11 publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2010.02.337 contributor: fullname: AS Levey – volume: 99 start-page: 475 issue: 5 year: 2007 ident: 256_CR26 publication-title: Eur J Appl Physiol doi: 10.1007/s00421-006-0375-6 contributor: fullname: K Sanada – volume: 73 start-page: 473 issue: 4 year: 2008 ident: 256_CR32 publication-title: Kidney Int doi: 10.1038/sj.ki.5002701 contributor: fullname: V Perkovic – volume-title: Nephrol Dial Transplant year: 2011 ident: 256_CR14 contributor: fullname: K Praditpornsilpa – volume: 29 start-page: 1872 issue: 8 year: 2006 ident: 256_CR16 publication-title: Diabetes Care doi: 10.2337/dc05-2141 contributor: fullname: W Aekplakorn – volume: 53 start-page: 766 year: 2007 ident: 256_CR21 publication-title: Clin Chem doi: 10.1373/clinchem.2006.077180 contributor: fullname: AS Levey – volume: 53 start-page: 932 issue: 6 year: 2009 ident: 256_CR25 publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2009.02.011 contributor: fullname: AD Rule – volume: 110 start-page: c39 year: 2008 ident: 256_CR7 publication-title: Nephron Clin Pract doi: 10.1159/000151244 contributor: fullname: RJ Glassock – volume: 16 start-page: 224 issue: 3 year: 1990 ident: 256_CR31 publication-title: Am J Kidney Dis doi: 10.1016/S0272-6386(12)81022-5 contributor: fullname: RD Perrone – volume: 130 start-page: 461 year: 1999 ident: 256_CR8 publication-title: Ann Intern Med doi: 10.7326/0003-4819-130-6-199903160-00002 contributor: fullname: AS Levey – volume: 56 start-page: 32 issue: 1 year: 2010 ident: 256_CR13 publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2010.02.344 contributor: fullname: M Horio – volume-title: Kidney Int year: 2011 ident: 256_CR3 contributor: fullname: BC Astor – volume: 4 start-page: 77 issue: 1 year: 2009 ident: 256_CR28 publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.03720708 contributor: fullname: R Agarwal – volume: 74 start-page: 358 issue: 5 year: 2010 ident: 256_CR22 publication-title: Clin Nephrol doi: 10.5414/CNP74358 contributor: fullname: D Giavarina – volume: 25 start-page: 1567 issue: 5 year: 2010 ident: 256_CR20 publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfp669 contributor: fullname: A Ingsathit – volume-title: Kidney Int year: 2011 ident: 256_CR24 contributor: fullname: M van der Velde |
SSID | ssj0017840 |
Score | 2.0536625 |
Snippet | Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) group recommended that patients with CKD should be assigned to stages and composite relative... BackgroundRecently, the Kidney Disease: Improving Global Outcomes (KDIGO) group recommended that patients with CKD should be assigned to stages and composite... Abstract Background: Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) group recommended that patients with CKD should be assigned to stages and... BACKGROUNDRecently, the Kidney Disease: Improving Global Outcomes (KDIGO) group recommended that patients with CKD should be assigned to stages and composite... BACKGROUND: Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) group recommended that patients with CKD should be assigned to stages and composite... Abstract Background Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) group recommended that patients with CKD should be assigned to stages and... |
SourceID | doaj pubmedcentral biomedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 1 |
SubjectTerms | Adult Asia, Southeastern - ethnology Asian Continental Ancestry Group - ethnology Chronic kidney failure Cohort Studies Demographic aspects Disease EGAT Epidemiology epidemiology, classification Female Glomerular Filtration Rate Guidelines as Topic - standards Health Surveys Hospitals Humans Identification and classification kidney Kidney diseases Male Measurement Medicine Middle Aged Nephrology Prevalence Quality control Quality standards renal failure Renal Insufficiency, Chronic - ethnology Renal Insufficiency, Chronic - physiopathology Risk Factors Statistics Studies Thai Young Adult |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4s3SguaAxClqbCd-cFtatoWqICEq9WY5sbNUQtmyj3_CD2bGya7W9MCFa2wnduZpe-Ybxt5G2wYVNWm_2BZVF0zhRdeiXBE0SAyyScVgLr-o86vq83V9vVfqi2LCBnjg4ccd-wpFAK28r03AvUCwnZadaWywQtjWDzifvN5upsb7A22GVEhUvYWQyo5wjdyo492zgsuC_5Xn_jMzTwnF_66u3jNWeSDlnmWaPWIPR5cSpsNSHrN7sX_C7l-Ol-ZP2W9kBRiyIWHRwbYkyhrOZt-AQDbIae3nEH8NsN8rWPSAfiHcLgkLnESfxp1cnILvA1AwOqRkkBXc9OAhVeGjEkAwpYxMoJq7yzVQRP08vQc9d7g4_XT2FeYbQtWiSPtn7Gr28fvJeTEWYygaVep10WhvIu7OIo-yFE3lQ7S2qlu6mTSmRUvvSxsMErfWPHRexU4iEyDdbYUuD5fP2UG_6ONLBrzufFuLphFGVYGHxpcBuwhTWul9lBP2PqOJux2ANxxBYectKJWOCOqIoI5Lxyfs3ZaAu3Fpo2PUnZ4fiL7Z29MDZD83sp_7F_vh54g7HKkDnFHrx6wGXCkBa7mp0NZqa2o1YUdZTxTjNms-3PKXG9XIylk6Sa65xrnCrpUGUmRcHxeb1EWTD1lO2IuBGXcLQtcP3d0S56gzNs1WnLf0Nz8SxLgk4EgpX_2PX3TIHqCXKdK5lTpiB-vlJr5GT27dvElC-wd7OkVP priority: 102 providerName: Directory of Open Access Journals – databaseName: PubMed (Medline) dbid: RPM link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbaHhAXxJulBc0Bqad0kziJbW7Llm2hWkCISr1Zju0sK7XZZR__hB_MjDdZ1eqNa_yQrXnHM98w9sEr6yovSPt5mxSNk4nJG4tyRdAg3vE6NIOZfqsur4uvN-XNASv7WpiQtG_r-Vl7e3fWzn-H3MrlnR32eWLDH9MxJ1g7zoeH7FBw3ofo3dOBwJClQ2fMZDXMUPsmOa9UkvGE-sKgQUQngJpkRRXut5FhCvj9D7X0PTMVp1Des0mTp-xJ50zCaHfoZ-zAt8_Zo2n3XP6C_UUmgF0dJCwa6JuhbOBi8hMIXoPc1XYG_s8O8HsNixbQI4TlilDASehp3fjqHEzrgNLQIZSBrGHegoHQf4-a_8CIajGBuu2uNkC59LOwD_rscHX-5eI7zLaEp0U59i_Z9eTzr_Fl0rVhSOoqFZukFkZ6jMt85nma14VxXqmitPQmKaVFG29S5SSStRSZa0zlG47kR4qrAp2djL9iR-2i9W8YZGVjbJnXdS6rwmWuNqnDKblMFTfG8wH7GNFEL3eQG5pAsOMRlEdNtNVEW51xnQ3YaU_A_boQ4sjqwcxPRN9o9_BhsZrpjtG0KVD3ontpSukwCHWqEbyRtXIqz5U1eNZT4g5NigBPZE1Xz4A3JUgtPcqFUkLJshqwk2gmCrCNho97_tKdAllrRf-Qy0zgWWE_SgspJ671i22YIsh7TAfs9Y4Z9xfqeXzARMSm0Y3jEZS1AC7eydbb_155zB6jU5mH31TVCTvarLb-HTpum_p9ENR_mJlEWg priority: 500 providerName: National Library of Medicine – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEBZtAqWX0ne3ScscCjmZWJJtSb2UzbsNSUtoIDchW_I2UOzNPv5Jf3BntNolbqBXSzISMxp90sx8w9inYBpfBUXWLzRZ0XqdOdE2uK-IGiR4WcdiMBeX1dl18e2mvEmxOfMUVrm2idFQ-76hN_J9Q49qJVf8y_Quo6JR5FxNFTQes23BC_LSbh8cX_642rgRFF5fElMj19U-R0ucCVmZjMuM_5Pi_ntwMkUC_4dm-t45NYyhvHconTxnzxKahPFK_C_Yo9C9ZE8ukr_8FfuDWgCrREjoW1hXQ1nA6ckVEL8G4dVuAuFuxfg9h74DhIQwnRENOO16Gnd4fgSu80Bx6BDzQOZw24GDWICPqv_AmJIxgcrtzhZAwfST-B8E7XB-9PX0O0yWRKhFQfav2fXJ8c_DsyzVYcjqKleLrFZOB7yYBR5kLurC-WBMUTbklNS6wUPe5cZrlGupuG9dFVqJ8keRmwLRDpdv2FbXd-EdA162rilFXQtdFZ772uUeuwidG-lckCP2eSATO11xblhiwR62oHJYEqglgVouLR-xvbUAN-PiHUdXD3oekHwHf48f-tnEpi1rXYHGF_GlK7XHW6g3rZKtro03QpjG4Vz3SDssWQKcUeNSQgOulDi17FgoY5TRZTViu4OeuIObQfPOWr9ssiBzu9H3EYNNKw2koLgu9MvYRRF8zEfs7UoZNwtC1IdIN8c5qoGaDlY8bOluf0V2cUmckVK-_--kdthTRI4ivkVVu2xrMVuGD4jOFvXHtAf_Ak5tPGY priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZQkRAXxJulBc0BqadAYiexjYTQ0rItVAsSYqXeLCd2lkpVts1mpfZ_8IOZcbLbhuXGNbYjO_Pw53jmG8beeF263Evyfr6M0sqpyPKqRLsiahDvRBGKwUy_5cez9OtpdnoT_9R_wOU_j3ZUT2rWnL-9urz-iAb_IRi8yt8l6GAjLnIdJSLCk9BdnoqUtH2a3twoSNUlR6779gSO2-P_ynw_H2xYgdd_23vf2r6GoZW39qrJQ_agB5kw7rTiEbvj68fs3rS_Rn_CfqNyQJcfCYsK1kVSWjia_ACi3SAYW8_BX3ZE4EtY1IBIES4aYgcnZ0DjDk4OwdYOKDwdQnrIEs5qsBDq8lFRIBhTjiZQFd6mBYqxn4f3IJaHk8MvR99hviKeLYq9f8pmk88_D46jvjxDVOSxbKNCWuXxvOYTL2JepNZ5rdOspLtKpUrc-22snUJxZzJxlc19JVAtUBN0iiAoEc_YTr2o_QsGSVbZMuNFwVWeusQVNnbYhatYC2u9GLH3A5mYi46KwxA59rAF7dSQQA0J1CTCJCO2vxbgZlw4-qh8q-cnku_g7eHBopmb3pKNTdEnI-y0mXJ4OHW6kqJShXaac11anOs-aYchlcUZlbbPc8CVEtWWGXOptdQqy0dsb9ATDbscNO-u9cus7cJo-recJRLnCptWGkixcrVfrEIXSagyHrHnnTJuFoRgEAFwjHOUAzUdrHjYUp_9CqTjgqgkhXj5P5LYZfcRb_LwByvfYztts_KvENO1xetgrH8AmJ1LOw priority: 102 providerName: Scholars Portal |
Title | The impact of different GFR estimating equations on the prevalence of CKD and risk groups in a Southeast Asian cohort using the new KDIGO guidelines |
URI | https://www.ncbi.nlm.nih.gov/pubmed/22226403 https://www.proquest.com/docview/920075171 https://search.proquest.com/docview/920784670 http://dx.doi.org/10.1186/1471-2369-13-1 https://pubmed.ncbi.nlm.nih.gov/PMC3274433 https://doaj.org/article/a4376456a58d401d9f73f8b9d9229ca3 |
Volume | 13 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFLZgkxAviPvKRnUekPYUEcdJbPPWbutGpw40mFTxYjmxUyahdPTyT_jBnOOkZVkfeUmk2I5sfT7258v5DmMfvC5d7iWNfr6M0sqpyCZViXZF0iDeiSIEg5lc5Rc36XiaTf_tdzw4wecq_8hx-IwSkeuIiwjXOfsJSZzTunz4Y3teIFXj-rjJ28oz7pZ_4Nf-qzMdBdX-3bH53uTUvTh5byYaPWfPWgoJgwbzF-yRr1-yJ5P2kPwV-4PQQ-P9CPMKNiFQVnA-ugYS1SCSWs_A_25kvpcwrwF5INwtSPubTJ3KnVyegq0d0OVzCM4fS7itwUKIukchf2BAHphAMXYXK6Ab9LPwH2TqcHn6-fwLzNakokU361-zm9HZ95OLqA2-EBV5LFdRIa3yuBrz3Is4KVLrvNZpVtJJpFIlzuw21k4hmJnkrrK5rwSCjjjrFCkOF2_YXj2v_QEDnlW2zJKiSFSeOu4KGzvMkqhYC2u96LFPHUzMXSO0YUj6upuCVmgIUEOAGi4M77HjDYDbcmFho_KdnEPCt_P38AF7m2nt1NgUR1wklTZTDpeeTldSVKrQTieJLi3W9Zh6hyHzxxqVtvViwJaSkJYZJFJrqVWW99hRJyeabdlJPtz0L9MOG0ujaec44xLrCttUKkg34Wo_X4cskjhj3GNvm864bRBSPaS3MdZRdrppp8XdlPr2Z5AUFyQUKcS7_0HikD1FNpmE_an8iO2tFmv_Hhnbquizx3Iq-2x_MBh_G-N7eHb19bof9j_wOUlVP5hzP2y2_QWq0ESe |
link.rule.ids | 108,230,315,733,786,790,870,891,2115,2236,12083,21416,24346,24965,27955,27956,31752,31753,33777,33778,43343,43838,53825,53827,76167,76168 |
linkProvider | BioMedCentral |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZgKwEXxJulBeaA1FPUOE5imwvaPrdsd0FVK_VmObGzVELJdh__hB_MTNa7aqjENbYjW_PwZ3vmG8a-eF263Evyfr6M0sqpyCZViXZF1CDeiaItBjOe5MPr9PtNdhNicxYhrHLjE1tH7ZqS7sgPNF2qZVzyb7O7iIpG0eNqqKDxmO0Q46bqsZ3Dk8nPy-0zgsTjS2Bq5Co_4OiJo0TkOuIi4v-kuP_u7Ewtgf9DN31vn-rGUN7blE5fsOcBTcJgLf6X7JGvX7En4_Be_pr9QS2AdSIkNBVsqqEs4ez0Eohfg_BqPQV_t2b8XkBTA0JCmM2JBpysnsYdjY7B1g4oDh3aPJAF3NZgoS3AR9V_YEDJmEDldudLoGD6afsfBO0wOj4_-wHTFRFqUZD9G3Z9enJ1NIxCHYaoyGO5jApplceDmedexEmRWue1TrOSHiWVKnGTt7F2CuWaSe4qm_tKoPxR5DpFtMPFW9arm9q_Z8CzypZZUhSJylPHXWFjh10SFWthrRd99rUjEzNbc24YYsHutqByGBKoIYEaLgzvs_2NALfj2jOOyh_0PCT5dv7efmjmUxNM1tgUnS_iS5sph6dQpyspKlVop5NElxbnuk_aYcgT4IxKGxIacKXEqWUGidRaapXlfbbX6YkWXHaadzf6ZYIHWZitvvcZbFtpIAXF1b5ZtV0kwce4z96tlXG7IER9iHRjnKPsqGlnxd2W-vZXyy4uiDNSiA__ndRn9nR4Nb4wF-eT0S57higyae-l8j3WW85X_iMitWXxKdjjX24gP1w |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LbxMxELaqIlVcEG9CC8wBqaelu-tdP7ilDWlKaEEVlSoulnftTSvKJuTxT_jBzHg3UZYeuUXxeGVrxuNvbM83jL33unTCS_J-voyyyqnIplWJ64qoQbzjRSgGc34hRlfZ5-v8eoeN1rkwxa-y9jiNcKb8YTsF_S74bfxR_jyauapZ7kocJeheo5QLHSU8wjjoAQbmgsKwy-Mfm_sEqZrUyLVsS994v_8_ee93ne0qsPrf991bm1f3YeXWTjV8zB61EBP6jU08YTu-fsr2zttL9GfsD5oGNNmRMK1gXSJlCafDSyDSDQKx9QT874YGfAHTGhAnwmxO3ODkCqjfyXgAtnZAj9MhJIcs4LYGC6EqH5UEgj5laALV4J0vgV7YT8J3EMnDeHB2-hUmK2LZopf3z9nV8NP3k1HUFmeIChHLZVRIqzxGaz7xPE6LzDqvdZaXdFOpVIk7v421U6jsXCaussJXHI0C7UBnCIES_oLt1tPav2KQ5JUt87QoUiUyl7jCxg5FUhVrbq3nPfaxoxMza4g4DFFjd1vQRAwp1JBCTcJN0mOHawVu-oXAR4l7ksek387Xwx_T-cS069jYDD0ygk6bK4ehqdOV5JUqtNNpqkuLYz0k6zDkHshWbZvlgDMloi3TT6XWUqtc9NhBRxKXddlp3l_bl2ndysJoOlnOE4ljhU0rdaSXcrWfroKIJEwZ99jLxhg3E0IoiPA3xjHKjpl2ZtxtqW9vAuU4JyJJzl__jybesb1vg6H5cnYx3mcPEXim4ShLHLDd5Xzl3yC4WxZvw7r9C49RTTI |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+impact+of+different+GFR+estimating+equations+on+the+prevalence+of+CKD+and+risk+groups+in+a+Southeast+Asian+cohort+using+the+new+KDIGO+guidelines&rft.jtitle=BMC+nephrology&rft.au=Kitiyakara%2C+Chagriya&rft.au=Yamwong%2C+Sukit&rft.au=Vathesatogkit%2C+Prin&rft.au=Chittamma%2C+Anchalee&rft.date=2012-01-06&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2369&rft.eissn=1471-2369&rft.volume=13&rft.issue=1&rft.spage=1&rft.epage=1&rft_id=info:doi/10.1186%2F1471-2369-13-1&rft.externalDBID=n%2Fa&rft.externalDocID=oai_biomedcentral_com_1471_2369_13_1 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2369&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2369&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2369&client=summon |